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CHARACTERIZATION OF p62, HAHl AND THEIR INTERACTION WITH
THE WILSON DISEASE PROTEIN
Paul Sifuna Oshule, M.S.
Western Michigan University, 2008
Wilson disease is an autosomal recessive disorder resulting in the
accumulation of copper in the body primarily in the liver and brain. In order to
understand the pathogenesis of Wilson disease, our laboratory is studying several
different proteins. Wilson disease protein (ATP7B) is a P-type ATPase which acts to
remove excess copper from the cells. The p62 subunit of the dynactin complex is a
protein whose function is still unknown but it has been proposed to have a copper
dependent interaction with ATP7B. HAHl is a human metallochaperone that binds
copper as it comes into the cells from CTRl, a permease. HAHl then shuttles copper
ions to one or more of the domains at the N-terminus of ATP7B. Copper binding
occurs via the thiol groups on two cysteines of HAHl and the copper-binding
domains of ATP7B.
In order to study protein-protein interactions we have cloned and expressed
these proteins. Three different vector constructs of p62 protein were prepared and
tested. Using site-directed mutagenesis we also generated mutants of both HAHl and
WLN4 (copper-binding domain 4 of ATP7B) and used them to study copper
dependent interactions. We have used the two mutants pHAHl(Cl1A,Cl4A) and
pTRX-WLN4(C15A,C18A) to serve as controls in the study of copper exchange
between HAHl and WLN4.
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CHAPTER I

INTRODUCTION

One in 30,000 people suffer from Wilson's disease. Wilson's disease was
described in 1912 by Samuel Kinner Wilson (Wilson, 1912). Clinical manifestations
of Wilson's disease include liver disease, neurological symptoms and Kayser
Fleischer rings caused by disrupted copper metabolism. Described as an autosomal
recessive genetic disorder of copper transport Wilson's disease leads to copper
accumulation in the liver, brain, and kidneys (Cumings, 1948). It is caused by a
mutation of the Wilson disease protein (mapped to gene atp7b on chromosome 13).
The human Wilson protein (WLNP) is a copper-transporting P-type ATPase located
in the secretory pathway and plays an important role in copper transport and
homeostasis.
The Wilson disease protein plays a key role in copper distribution in the liver,
kidney, and the brain. WLNP utilizes the energy of ATP hydrolysis to transport the
metal into the secretory pathway for incorporation into such copper-dependent
enzymes as ceruloplasmin or be expelled from the cell if copper is in excess
(Lutsenko & Petris, 2003). WLNP and other eukaryotic copper-ATPases are unique
among the P-type ATPases because they do not bind copper directly from the cytosol;
where the amounts of free copper are extremely low. WLNP receives the metal ion
from a small cytosolic protein called a metallochaperone through direct protein
protein interactions with human Atox1 (Achila et al., 2006;

Larin et al., 1999;

Pufahl et al., 1997). The focus of this thesis was to study interactions between the
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human Wilson disease protein and its partners, namely: HAHl, a copper
metallochaperone (Klomp et al., 1997) and a recently discovered p62 subunit of the
dynactin complex (Lim et al., 2006).
1.1 Significance of copper metabolism
Many trace elements require a delicate homeostatic balance to ensure the
cellular processes work efficiently. However, variations affecting these processes lead
to toxicity, due to excessive accumulation of these elements. Copper is required for
numerous cellular processes, including mitochondrial respiration, antioxidant defense,
neurotransmitter synthesis, connective tissue formation, pigmentation, peptide
amidation and iron metabolism as seen in Table 1 (Kaler et al., 1994; Kaler, 1998;
Linder, 199-1).
Table 1
Functions of copper-dependent enzymes.
Enzyme

Function

Ceruloplasmin

Iron and copper transport

Cytochrome C oxidase

Mitochondrial respiration

Dopamine B-hydroxylase

Catecholamine production

Lysyl oxidase
Connective tissue
Peptidylglycine
a- Peptide amidation
amidating mono-oxigenase
Superoxide dismutase
Antioxidant
Tyrosinase

Pigment formation

Consequences of
deficiency
Decreased circulating
copper levels, iron
deficiency
Hypothermia, muscle
weakness
Hypothermia, neurological
defects
Laxity of skin and joints
Neuroendocrine defects
Diminished protection
against oxidative stress
Hypopigmentation of hair
and skin
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Dietary copper is absorbed into the body through the intestinal mucosa where
it joins recycled endogenous copper secreted into the gastrointestinal tract from other
tissues (Linder, 1991). In general, dietary copper absorption is dependent upon the
amount of copper reabsorbed from the fluids of other tissues. Newly absorbed copper
is transported to body tissues in two phases. First, albumin, transcuprein, amino acids,
and a group of uncharacterized low molecular weight proteins transport the majority
of exchangeable copper to the liver (Linder, 1991). After traversing the basolateral
membrane of hepatocytes, copper is distributed to endogenous copper-requiring
enzymes and to secreted cuproproteins such as ceruloplasmin, which is thereafter
released to plasma for delivery of copper to other tissues. Copper's ability to exist in
distinct redox states allows it to function as a critical catalyst. The diversity of
function and tissue expression of most of the copper proteins reveal an important role
for copper in mammalian systems. Any excess copper is excreted to the bile by the
way of the canalicular (apical) plasma membrane (Shim & Harris, 2003).
In amounts that exceed cellular needs copper is highly toxic, owing to its
potential to facilitate the production of reactive oxygen species by means of Fenton
chemistry (Stohs & Bagchi, 1995). Cu(I) and Cu(II) ions can bind with high affinity
to adventitious sites in partially folded proteins as well as catalyze auto-oxidation of
lipids, proteins, and nucleic acids (Pufahl et al., 1997). Thus, intracellular copper
concentrations must be rigorously controlled such that copper is provided to essential
enzymes (Table 1), but does not accumulate to toxic levels (Rosenzweig, 2001).
Refined mechanisms have evolved to regulate intake, excretion and the
cellular distribution of copper. The importance of these regulatory mechanisms is
underlined by several hereditary human disorders of copper homeostasis. These
disorders can broadly be divided into two classes: (1) diseases associated with copper
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deficiency (Menkes disease, (Menkes et al., 1962)) and occipital horn syndrome
(Kaler et al., 1994; Menkes et al., 1962) and (2) diseases associated with copper
excess, Wilson disease (Wilson, 1912).
1.2 Menkes disease protein
The Menkes protein belongs to a large family of cation-transporting P-type
ATPases, a human copper(I)-transporting P-type ATPase also known as ATP7A.
Mutations in ATP7A may lead to a fatal X-linked copper deficiency syndrome, the
Menkes disease (Menkes et al., 1962). Hence, ATP7A is often referred to as the
Menkes protein (MNK). Menkes disease causes a defect with copper transport across
membranes, particularly in intestinal mucosa! cells where copper efflux is impaired
(Voskoboinik et al., 2001).
This protein has two important cellular functions: first, to facilitate the export
of copper from non-hepatic tissues and its absorption into the circulation, and
secondly to deliver copper to the secretory pathway for incorporation into copper
dependent enzymes. To carry out both functions, MNK must be correctly localized
within distinct subcellular compartments, which is achieved through a copper
dependent trafficking of the polypeptide (Petris et al., 1996).
MNK contains four major regions/domains (the N-terminal copper binding
region, eight transmembrane domains, the ATP-binding domain, and the activator
domain) and a short C-terminal tail. The N-terminal copper binding cytosolic tail of
MNK is ~650 amino acids long and contains six 70-amino acid independently folded
domains, which have a sequence similarity and structure homology (Amesano et al.,
2002; Banci et al., 2004; Banci et al., 2005). Each domain harbors the conserved
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sequence motif GMXC:XXC, through which it can bind one equivalent of copper(!)
(DiDonato et al., 2000; Lutsenko et al., 1997).
1.3 Wilson disease protein
The copper transporting P-type ATPases (designated CPx-type ATPases) are
distinguished from other P-type ATPases (Arguello et al., 2007), by the presence of a
large N-terminal metal-binding domain with six metal binding sites (MBS) (Figure
1). These domains contain repeats of a GMXCXXCXXXIE motif evolutionarily
conserved in heavy metal-binding proteins. The number of these motifs varies
between phylogeny (Arnesano et al., 2001). The Wilson disease protein (WLN) and
the Menkes protein (MNK) are each comprised of six metal binding domains (WLN)
which are about 70 amino acids long and share homology (Bull et al., 1993).
According to yeast two-hybrid assays using Wilson disease N-terminal
domains (WLNs) and MNK (Larin et al., 1999; van Dongen et al., 2004), domains 1
to 4 of the N-terminal (WLNI-4) interact most strongly with Atoxl, whereas no
interaction is observed with domains 5 and 6. This observation has been verified by
high resolution NMR experiments on the individual domains WLN2 and WLN4
(Achila et al., 2006).
The interaction is dependent on the conserved cysteine residues, as verified in
NMR titrations with HAHi and MNK (Banci et al., 2007). In contrast to the two
hybrid data, an interaction between MNK, domains 5 and 6, and Atox1 was detected
by surface plasmon resonance studies (Strausak et al., 2003). Copper transfer studies
between HAHi and WLNI-6 also show transfer to each of the individual domains
(Yatsunyk & Rosenzweig, 2007). The latter experiment is, however, not capable of
resolving complex formation as seen by a number of 1 H- 15 N HSQC titrations between
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the metallochaperones and their target domains (Achila et al., 2006; Arnesano et al.,
2001; Banci et al., 2006).

N-terminaJ
c<>pper-binding domain

ATP-blndl,ng domain

Figure 1 Transmembrane organization of the six metal-binding sites in the N
terminal domain of WLNP with metal binding motifs indicated by the
letters CXXC (Huster & Lutsenko, 2003).
1.4 Mutations in the Wilson disease protein gene
It is known that copper binding requires two cysteine residues for a linear
digonal environment; a transient docking of metallochaperone and target is thought to
be mediated by a transient three coordinate complex, with the third ligand given by
the target or donor (in the case of transfer to target). The absence of one residue will
cause a failure of copper acquisition. In their study of interactions of the third metal
binding domain of the Menkes disease protein Banci and coworkers using a
homologous system, Atxl-Ccc2 found in yeast, concluded the that removal of
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cysteines eliminates copper-dependent interaction between WLN and HAHi (Banci
et al., 2006). This mutation of the metal binding motif in WLN4 may also inhibit
HAHi delivery of copper. Pufahl and coworkers have proposed a mechanism by
which copper is delivered, through metal mediated protein-protein interaction, to its
target protein in a bucket brigade mechanism (Pufahl. et al., 1997). Recent studies,
showing that all the copper-binding domains have similar apparent affinity constants
argue against this (Wernimont et al., 2004; Yatsunyk & Rosenzweig, 2007). A
bucket brigade requires flowing of Cu(I) ions down a shallow thermodynamic
gradient. It is more likely that Le Chatelier's principle is at work, since Cu(I) is being
removed from one compartment into another via the action of ATP; such a
mechanism was alluded to later (Huffman & O'Halloran, 2000).
The human copper chaperone HAHi is capable of delivering copper(!) both to
the Menkes and the Wilson disease proteins (Hamza et al., 1999). These two proteins
are membrane-bound P-type ATPases which translocate copper in the trans-Golgi
network or across the plasma membrane, depending on the environmental conditions.
Homologues of both HAHl and ATP7A/ATP7B are found in a number of
prokaryotic and eukaryotic organisms; however, it is noteworthy that the genome of
some organisms may encode only one of the two partners (Anastassopoulou et al.,
2004; Amesano et al., 2001).
The p62 subunit of the dynactin complex has been cloned and expressed (Lim
et al., 2006). p62 subunit of the dynactin complex is one of the other proteins that
have been shown to interact with the Wilson disease protein (ATP7B) (Lim et al.,
2006). The most striking feature of the p62 polypeptide is a very highly conserved
pattern of cysteine residues (Karki et al., 2000). The primary sequence of p62 subunit
of the dynactin complex predicts a protein of 53 kDa with a zinc-binding motif near
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the N terminus. Such motifs are commonly known to support protein-protein
interactions (Karki et al., 2000; Schroer, 2004). It was proposed that p62 uses this
region to bind other dynactin subunits, or membrane-associated phospholipids (Karki
et al., 2000; Schroer, 2004). p62 has two additional cysteines in the C-terminal which
form the highly conserved, functionally important, _CxxC motif which may be
implicated in the copper-dependent interaction
between p62 and ATP7B (Lim et al.,
•
2006).
The copper chaperone HAHI interacts with the N terminus of both ATP7A
and ATP7B in a copper-dependent manner, and this interaction assists copper
delivery to the secretory pathway. COMMD 1 (MURRI), which is mutated in
Bedlington terriers suffering from copper toxicosis (van De Sluis et al., 2002),
interacts with the N terminus of ATP7B (Tao et al., 2003). The fact that COMMDl
interacts with ATP7B but not with HAHl or ATP7A is consistent with its proposed
role in copper excretion from the liver (Tao et al., 2003).
Despite their sequence and structural similarity and the presence of six MBS
within the N-terminus of the copper ATPases, there are differences in sequence as
well as structure that confer specificity of interactions with proteins such as
COMMD 1 and differences in their trafficking pathways. The identification of a
putative targeting signal in ATP7B that is not present or is different in ATP7A
suggests that additional specific protein interactions are likely to impact on their
activity (Tao et al., 2003).
1.5 HAHl Metallochaperone (Human homolog of Atxl)
Metallochaperones are a newly discovered and important class of enzymes
that transport metal ions into specific partners (O'Halloran & Culotta, 2000). After
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uptake, distribution of intracellular copper is facilitated by a group of proteins called
copper chaperones, which function to deliver free copper to pertinent sites around the
cell. Until recently it was thought that once copper is taken inside the cell it would be
sequestered by sulfhydryl copper ligands, like those found in metallothioneins and
glutathione, which are abundant in most cell types (Camakaris et al., 1999; Freedman
et al., 1989). The role of metallothioneins in normal copper homeostasis was cast into
doubt by the absence of a copper-related phenotype in the metallothionein knock-out
mice (Kelly & Palmiter, 1996). However, metallothionein knock-out mice which also
carry the Mottled-Brindled allele (MNK mutant allele in mouse) showed
embryolethality suggesting metallothioneins do play a role in protection against
copper toxicity (Freedman et al., 1989). Little was known about the intracellular
transport of Cu until the recent identification of several copper binding proteins
termed Cu chaperones. These proteins were first identified in yeast, and their
homologues were subsequently discovered in mammalian cells. In contrast to
metallothioneins which sequester Cu into an extremely stable heptacopper thiolate
cluster buried within the tertiary fold, chaperones bind Cu in labile complexes which
enable ligand exchange when docking to a target protein (Portnoy et al., 1999;
Pufahl et al., 1997; Srinivasan et al., 1998). These copper chaperones protect the cell
from potential cytotoxic reactions caused by free metal ions. Several mutations in
WLN originally found in Wilson's disease patients were shown to disrupt the HAHl
WLN interaction, suggesting that HAHl is required for Wilson disease protein
function (Hung et al., 1997).
These copper chaperones were first isolated in the baker's yeast
Saccharomyces cerevisiae (Lin & Culotta, 1995; Pufahl et al., 1997), and functional
homologs have been noted in humans (Klomp et al., 1997), sheep (Lockhart et al.,
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2000), mice (Nishihara et al., 1998), Arabidopsis thaliana (Himelblau et al., 1998),
and Caenorhabditis elegans (Wakabayashi et al., 1998). Both the yeast Atx1 and the
human Atxl homolog (HAHl or Atoxl ) specifically traffic copper to the secretory
pathway for incorporation into copper enzymes destined for the cell surface or
extracellular environment (Hung et al., 1997; Klomp et al., 1997; Pufahl et al.,
1997).
HAHi is a small soluble, single-domain cytoplasmic protein containing a
conserved CxxC motif that binds Cu(I). The bound Cu(I) is then transferred from
HAHl to a WLN metal binding domain through direct and specific HAH1-WLN4
protein-protein interactions (Achila et al., 2006).
1.6 Copper transfer between the HAHi and WLNs
It is likely that the role of each Wilson disease N-terminal domain is
dependent on and defined by its environment. Direct evidence for the presence of a
copper exchange mechanism between a Cu chaperone and acceptor protein has been
provided recently by several groups (Huffman & O'Halloran, 2000; Yatsunyk &
Rosenzweig, 2007).

For example, Cobine and coworkers (Cobine et al., 2002)

demonstrated that the CopY repressor accepts Cu from the CopZ chaperone in
bacteria. The described yeast and human Cu chaperones have similar MBSs, therefore
it is likely that other surface motifs (or individual amino acid residues) on these
proteins may be responsible for a target-specific docking of Cu-loaded chaperones
(Bunce et al., 2006; Huffman & O'Halloran, 2001).
As stated before Atx l , HAHi, and the other "Atxl -like" chaperones and
target domains bind metal ions with the two cysteine residues in the conserved
MT/HCXXC motif which help in the binding of copper. Structural evidence for
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coordination by the conserved cysteines initially was suggested by the NMR structure
of the fourth domain of the Menkes protein in the presence of Ag(I) (Gitschier et al.,
1998); however, it is noted that direct coordination was not demonstrated - for
example, by interrogation of the metal center by X-ray absorption or emission.

Figure 2 The proposed mechanism of copper transfer between HAH 1 and a domain
of the Menkes or Wilson protein. HAHl is shown on the right, and the
target domain is shown on the left (Wernimont et al., 2000).
The first X-ray structure of a metallochaperone was that of Hg(Il)-Atxl
(Rosenzweig et al., 1999), and then several metal-bound structures of HAHl
followed (Figure 3) (Wernimont et al., 2000). The HAH 1 structures also provide a
three- dimensional model for target recognition and docking. Since Atx 1 and HAH 1
are very similar to the fourth Menkes domain in both overall fold and metal binding
site, the observed HAHl dimer can be considered a model for the chaperone-target
protein complex. The two HAHl molecules contact one another primarily at the site
of the shared metal ion as shown in Figure 3 above (Wernimont et al., 2000).
Once copper enters the hepatocyte bound to either albumin or histidine it
traverses the cell via the via the high-affinity human copper transporter, hCtrl (Figure
4) (Zhou & Gitschier, 1997). Characterization of hCtrl confirms localization on the
plasma membrane and also suggests the presence of hCtr1 on a separate intracellular
perinuclear vesicular compartment (Shim & Harris, 2003). Copper. once inside the
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hepatocyte, has one of three possible fates: i) joining the copper/metallothionein pool,
ii) binding to CCS for delivery to Cu, Zn-SOD, or iii) trafficking to the Wilson
disease P-type ATPase, which resides in the trans-Golgi network by HAHl for
subsequent copper incorporation into the cuproprotein ceruloplasmin. However, the
copper chaperone that delivers copper to cytochrome c oxidase is still unknown.
Recent studies indicate the possibility of mitochondrion matrix copper being the
copper source for cytochrome c oxidase (Cobine el al., 2006). Localization studies of
the Wilson P-type ATPase reveal redistribution of the ATPase from the trans-Golgi
network to a vesicular compartment that moves out toward the biliary epithelium
under conditions of high copper concentration providing a mechanism for copper
excretion in bile.

C'y!S l2R

l'y~ l:ZA

Cy~ 11B

Cys 12..\ Cys 12Jl

Figure 3 The structure of the Atx 1 human homologue, HAH 1. The metal ion 1s
coordinated by conserved cysteine residues (Wernimont et al., 2000).
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Figure 4 Model of copper trafficking in a hepatocyte.
1. 7 Other proteins that interact with the Wilson disease protein
1. 7.1 p62 subunit of the dynactin complex
This study also involved the isolation, characterization and purification of C
terminal portion of p62 subunit of the dynactin complex. The amino acid sequence of
the C-terminus portion of p62 is shown (Figure 5). p62 is a protein with a molecular
weight of about 25 kDa in size.
The p62 subunit contains a CxxC motif in the C-terminus that might be
involved in Cu(I) binding. There are also a number of potential histidine copper
ligands in this protein. It has been shown to interact with a portion of the N-terminus
that includes metal-binding domains 4-6 of the Wilson disease protein (Lim et al.,
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2006). Since the potential copper binding properties of the p62 protein has been
postulated by Lim and coworkers, this project aimed at isolating the p62 protein, then
use it to find out its metal-binding environment as well as its interaction with the
Wilson protein (Lim et al., 2006).
TEVTTLQQRL LQPDFQPVCA SQLYPRHKHL LIKRSLRCRK CEHNLSKPEF
51 NPTSIKFKIQ

LVAVNYIPEV

RIMSIPNLRY MKESQVLLTL TNPVENLTHV

101 TLFECEEGDP DDINSTAKW VPPKELVLAG KDAAAEYDEL AEPQDFQDDP
151 DIIAFRKANK

VGIFIKVTPQ REEGEVTVCF KMKHDFKNLA APIRPIEESD

201 QGTEVIWLTQ HVELSLGPLL P

Figure 5 Amino acid sequence of the p62 subunit of the dynactin complex. Note a
C:XXC motif in bold and underlined above.
Dynactin is a multi-subunit protein complex necessary for the function of the
cytoplasmic molecular motor, dynein, found in all eukaryotic cells. The coordinated
trafficking of organelles along microtubules is critical to the viability of cell and is
powered by the mechanochemical ATPases, kinesin and cytoplasmic dynein (Karki &
Holzbaur, 1995).
The dynactin is an important component of the cytoplasmic dynein motor
machinery (Holleran et al., 1998). It has two distinct structural domains: a projecting
sidearm that interacts with dynein and an actin-like minifilament backbone that is
thought to bind cargo (Karki et al., 2000). The dynactin contains 11 different subunits
which are known to interact with the cargo molecules (Figures 6, 7). The complex
binds to the motor and then carries it along microtubules along with the numerous and
diverse cargo molecules (Allan, 2000).
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Figure 6 Scheme illustrating the location and approximate structural features of
dynactin units (Schroer, 2004).
The most striking feature of the p62 polypeptide is a very highly conserved
pattern of cysteine residues. Comparisons of the sequences of p62 from human,
mouse, Drosophila, C. elegans, and N. crassa indicate a pattern of 11 highly
conserved cysteine residues (Karki et al., 2000). These cysteines are the ones most
likely responsible for the copper-dependent interaction with this protein. This
particular interaction is key to copper-regulated trafficking pathway that delivers
ATP7B to sub-apical vesicles of the hepatocytes for the removal of excess copper.
This has been proposed by Lim and coworkers who studied the N-terminus of ATP7B
and p62 interaction using a yeast two-hybrid technique. By mutating the cysteines in
all the six metal binding domains, the interaction was disrupted. The mutation
abolished the copper-regulated redistribution of ATP7B from the trans-Golgi network
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to sub-apical vesicular compartments and the copper transport activity (Forbes et al.,
1999; Lim et al., 2006; Petris et al., 2002).

Dynein int�rmediat�
chains

Figure 7 The model of the dynactin complex and its proposed interaction with
microtubules and cytoplasmic dynein (Allan, 2000).
1.7.2 MURRI (COMMDl)
Recently, the discovery of a mutated MURRl gene in Bedlington terriers
(inbred canine strain) with copper toxicosis provides a new lead to disentangling the
complexities of copper metabolism in mammals (van De Sluis et al., 2002).
Bedlington terriers are purebred dogs known to possess a high incidence of copper
toxicosis due to a defect in biliary copper excretion. MURR 1 functions in the
regulation of the transcription factor NF-,;B and control of copper metabolism.
Mutations in this gene are responsible for copper toxicosis in the Bedlington terriers.
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These species of dogs do not have mutations m ATP7B but display a
phenotype which is consistent with inactivation of copper export by ATP7B (van De
Sluis et al., 2002). In their coimmunocoprecipitation studies of COMMDl, Tao and
coworkers have demonstrated that COMMDl interacts with ATP7B through the N
terminal region of the protein. Since COMMDl does not coimmunoprecipitate with
ATP7 A it could be a specific regulator of hepatic ATP7B and provide a better
understanding of the copper homeostasis pathway (Burstein et al., 2005; Tao et al.,
2003).
1. 7 .3 Glutaredoxin
Glutaredoxin, an example of a sulfhydryl protein similar to thioredoxin, was
first discovered in 1976 as a thiol donor system for ribonucleic reductase in a mutant
lacking thioredoxin 1 (Trxl) in E. coli (H olmgren, 1976). Glutaredoxin (Grxl) is a
small cytosolic protein that catalyzes the reduction of disulfide bonds in proteins,
oxidizing glutathione (GSH) to glutathione disulfide (GSSG). GSSG is in turn
recycled to GSH by the enzyme glutathione reductase at the expense of NADPH.
During the reaction cycle it is thought that a cysteine pair in the active site of
glutaredoxin is converted to a disulfide (Shelton et al., 2005).
Using yeast-two hybrid technology and co-immunoprecipitation, Lim and
coworkers proposed that glutaredoxin interacts with the N-terminus the copper
ATPases ATP7 A and ATP7B. This interaction is copper -dependent and it requires a
CxxC motif and could have an essential role in maintaining the activity of the copper
ATPases (Lim et al., 2006). Glutaredoixn may act to reduce intramolecular disulphide
bonds formed by the cysteine residues to allow copper coordination by the thiol
groups during the copper translocation by these ATPases (Lim et al., 2006).
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Figure 8 A schematic representation of the glutaredoxin pathway (Carmel-Harel &
Storz, 2000).
1.8 Significance of this study
This study focused on trying to understand the various known proteins that
interact with the Wilson disease protein and how these copper-dependent interactions
will help elucidate copper homeostasis. The p62 subunit of the dynactin complex has
initially been identified as an interacting partner of ATP7B using yeast two-hybrid
assay (Lim et al., 2006). WLN4 is known to interact with HAHl directly for Cu(I)
transfer (Achila et al., 2006; Yatsunyk & Rosenzweig, 2007). An insightful study of
HAHl- WLN4 interactions will help understand how HAHi and the full length of
WLN interact for Cu(I) transfer.
The results of these experiments will generate new information regarding key
copper transporters in mammalian cells and will advance understanding of basic
mechanisms regulating intracellular copper distribution. Studies of interacting
partners of the Cu-ATPases will give more insights into the molecular mechanism of
regulating localization of these copper transporting proteins in the cell which have a
significant role in Wilson's disease and Menkes disease.
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1.9 Objectives of this study
This research was based on the study of copper-dependent interaction partners
with the Wilson disease protein: p62 subunit of the dynactin complex and HAHl, a
copper-chaperone, which delivers copper specifically to copper-transporting ATPases
in mammalian cells. One objective was to clone, over express and characterize the
p62 subunit protein of the dynactin complex. Among the studies that we will carry
out include copper interaction studies of the p62 protein with the N-terminal domains
of the Wilson disease protein.
The second objective was to generate mutants of HAHi and the fourth domain
of the Wilson disease protein (WLN4) by changing cysteines of the metal binding
motif CxxC to AxxA. Mutations will alter the properties of the holoHAHl.This will
be used in various copper binding studies to investigate the role played by the
cysteine metal binding motif in transfer of copper between HAHi and WLN4,
especially in the development of control studies.
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CHAPTER II

MATERIALS AND METHODS
2.1 Materials
A plasmid containing HAHl cloned into pETlld was available in our
laboratory (pETl ld-HAHl) and also the single mutant of Wilson disease protein
metal-binding domain four. The template for site-directed mutagenesis of pTRX
WLN4(C15A,C18A) was single mutant (WLN4(C15) that Ms. Sarah Dickenson and
Mr. Joshua Muia produced in the Huffman laboratory. The p62 gene was obtained as
a donation from Dr. Julian Mercer and Dr. Sharon LaFontaine of Deakin University,
Australia.
All the primers used were purchased from Integrated DNA Technologies, Inc.
Restriction endonucleases and other enzymes with their respective buffers were
purchased from New England Biolabs Inc. and Life Technologies. The nucleotides
were purchased from Sigma Chemicals Co., while bacterial strains and plasmids were
obtained from Novagen. The QIAGEN plasmid isolation and DNA isolation kits were
purchased from QIAGEN Inc. QuikChange® II XL (Stratagene, #200521) the site
directed mutagenesis kit was obtained from Stratagene. Dimethylsulfoxide, dibasic
potassium phosphate and sodium phosphate (monobasic and dibasic) all were
purchased from J.T. Baker Chemical Co. Other significant reagents were IPTG
(Isopropyl-B-D-thiogalactopyranoside,

!NALCO,

#1758-1400),

Agarose™

(Invitrogen, #15510-019), tryptone (MO BIO Laboratories, #12111-1), Bacto-yeast
extract (Fisher, #212720), NaCl (Fischer, #BP330-1), yeast extract (Fisher,
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#7264672, dextrose (Fisher, #BP350-l) and MES (2-(4-morpholino)-ethane
sulphonic acid, #BP300-100). Bio-Rad dye (#500-0006) for the Bradford assay was
obtained from Bio-Rad Laboratories while Coomassie plus dye (#B-0149) was
obtained from Pierce. Ampicillin (#A-9518) and Bacto-Agar (#214010) were from
DIFCO Laboratories. YM3 membranes for protein concentration were purchased
from Millipore.
2.2 Cloning of genes
Before cloning of the p62 gene into the pET24d plasmid vector, both forward
and reverse primers for p62 amplification were designed as described below.
2.2.1 Primer design
The primers were designed with the DNA Strider program. The sequence for
the forward primer was: 5'-CAA GAC CAG TAA CCA TGG CAG AGG TAA CAA
CCC TTC AGC AGC -3'. This primer design included a start codon ATG
(underlined) which codes for methionine and the Ncol restriction site CCATGG. The
sequence of the reverse primer was 5- CCC TCC AGT GGA TCC TTT TAA GGA
AGA AGT G -3'. This design incorporated a stop codon TGA and a unique
restriction site for BamHI, GGATCC.
2.2.2 p62 gene amplification
The gene encoding p62 was amplified using the Polymerase Chain Reaction
(PCR) utilizing the above designed primers (forward and reverse). Taking into
account the Guanine-Cytosine (GC) content and the melting temperatures of the
respective primers, the following written program was used to facilitate the
polymerization activity.
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Table 2
PCR reaction conditions for the p62 gene amplification.
Name

Temperature

Time

First denaturing

9s0c

5 min

Annealing

65 °C

1 min

Extension

n°c

40 sec

Second denaturing

9s0c

40 sec

Annealing

65 °C

1 min

Extension

n°c

1 min

The last two steps were repeated 30 times. This was followed by storage at 4°C. The
annealing temperature (Tm) was calculated from the composition of the primer
according to the Wallace rule (Equation 2.1).
Tm { ° C) = [(G + C) X 4] +[(A+ T) X 2]

2.1

A PCR product of 700 bp was obtained and visualized in an agarose gel
before purification. The product was subjected to purification using the QIAquick
Spin PCR purification kit. Purified DNA was analyzed using 1% Agarose gel
electrophoresis. The gel was stained in ethidium bromide and visualized under UV
light. The correct mass of the DNA was observed.
2.2.3 Ligation of p62 gene into pET24d
pET24d (Novagen) expression vector was digested using restriction enzymes
Ncol and BamHI. The purified p62 gene from the PCR reaction was then ligated see
figure below into the vector pET24d at 25 °C for 4 hr and the reaction conditions
maintained at 4°C.
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pET24d

Figure 9 Ligation of p62 into the pET24d vector.
The ligation products were analyzed by 1 % agarose gel electrophoresis. The
ligation was successful due to the agrarose gel electrophoresis analysis showing a
band of 700 bp size corresponding to the p62 gene.
The recombinant p62 gene was then expressed in DH5a E. coli cells using the
Invitrogen protocol described in the transformation kit and a time course induction
was carried out for 4 hr and the protein was induced using 1 mM IPTG. The resultant
protein was analyzed by 10% SDS-PAGE gel electrophoresis.

2.3 Ligation Independent Cloning (LIC) of p62 gene
Due to difficulty in expressing the p62 protein, the cloning method was
changed to use a fusion protein following the protocols described by Novagen book.
The second strategy of Ligation Independent Cloning was employed with vectors
coding for glutathione transferase (GST) and the thioredoxin tag respectively. These
LIC vectors are created by treating a linearized backbone with T4 DNA polymerase
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in the presence of dATP. The 3' to 5' exonuclease activity of T4 DNA polymerase
removes nucleotides until it encounters a residue that corresponds to the single dATP
present in the reaction mixture. At this point, the 5' to 3' polymerase activity of the
enzyme counteracts the exonuclear activity to prevent further excision. Plasmid
sequences adjacent to the site of linearization are de.signed to give specific non
complementary overhangs which in most cases are normally 13 to 14 base pairs in the
LIC vector. Fusion proteins are known to improve protein solubility and also enhance
protein purification. They also help in stabilizing the protein so that it gets made
efficiently. The illustration of Ligation Independent Cloning is shown in Figure10.
Both pET-41 Ek/LIC which is fused with N-terminal GST-Tag™ sequence
and pET-32 Xa/LIC fused with Trx-Tag™ thioredoxin protein (LaVallie et al., 1993)
were used in this study. These two vectors are designed for rapid and directional
cloning of PCR amplified DNA for high level expression of polypeptides with a
fusion protein. Specifically designed primers were inserted without the need for
restriction digestion or ligation and the resultant fusion protein can be cleaved by
proteases enterokinase in the case of pET-41 Ek/LIC and Factor Xa in the case of
pET32-Xa/LIC (LaVallie et al., 1993).
The sense primer was designed to encode the last four amino acids of the
enterokinase (Ek) cleavage site plus the C-terminal flanking amino acid Met. The
sequence of the GST fusion forward primer was: 5'- GAC GAC AAG ATG GCA
GAG GTA ACA ACC CTT CAG CAG CGT CTG - 3' and the sequence for the GST
fusion reverse primer was: 5'- GAG GAG AAG CCC GGT TTA AGG AAG AAG
TGG GCC CAA GCT AAG TTC - 3'. The primers for pET32-Xa/LIC were 5' GGT ATT GAG GGT CGC ATG GCA GAG GTA ACA ACC CTT CAG CAG CG
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- 3' (forward) and 5' - AGA GGA GAG TTA GAG CCT TAA GGA AGA AGT
GGG CCC AAG CTA AG - 3' (reverse).
Two PCR tubes were set up: The first tube contained 58 µL H 20, 10 µL
Thermopol buffer™(l0x), 10 µL 2 mM dNTP mix, 10 µL Ek/LIC p62 forward
primer (10 µM), 10 µL Ek/LICp62 reverse primer (10 µM), 2 µL template (p62), and
0.9 µL DNA polymerase (Deep Vent). This mixture was overlaid with 30 µL mineral
oil. The second tube contained: 58 µL H2 O, 10 µL thermopol buffer (lOx), 10 µL
2mM dNTP mix, 10 µL Xa/LIC p62 Fwd primer (10 µM), 10 µL Xa/LIC p62 reverse
primer( 10 µM), 2 µL templatep62), and 0.9 µL DNA polymerase (Deep Vent). The
two tubes were set in the PCR instrument and the desired DNA piece was amplified
using the following PCR program: Melting temperature of 95°C for 5 min, annealing
temperature of 65°C for 1 min, extension temperature of 72°C for 40 sec, melting at
95°C for 40 sec, annealing of at 65°C for 1 min and Extension at 72°C for 1 min. The
last 3 cycles were repeated 27 times (Table 2).
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Figure 10 Schematic representation of Ligation Independent Cloning technique.
(LaVallie et al., 1993).
After the DNA amplification, an agarose gel electrophoresis was run to
ascertain the presence of the DNA piece. The PCR product was then purified using
the Qiagen mini elute protocol. The purified product was also quantified by agarose
gel electrophoresis.
2.3.1 T4 DNA polymerase treatment of target insert
The following components were assembled in a PCR tube: 10 µL purified
PCR product, 2 µL T4 DNA polymerase buffer (l0X), 2 µL 25 mM dATP, 1 µL 100
mM DTT 0.4 µL T4 DNA polymerase (UC-qualified) and 4.6 µL nuclease-free
water. The total volume of the components was 20 µL. The reaction was started by
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adding the enzyme and stirring with the pipette tip for 2 min. The mixture was then
incubated at 22°C for 30 min. Finally the temperature was raised to 75 °C for 20 min
to inactivate the enzyme.
Table 3
PCR reaction conditions for the LIC experiment.
Name

Temperature

Time

First denaturing

94°c

5 min

Annealing

65 °C

1 min

Extension

n °c

40 sec

Second denaturing

9s 0c

40 sec

Annealing

65 °C

1 min

Extension

n °c

1 min

2.3.2 Annealing the vector and the treated insert (Ek/LICp62)
Annealing of the pET41Ek/LIC vector and the treated insert above
(Ek/LICp62) was done by assembling the following components in a sterile PCR
tube: 1 µL Ek/LIC vector (pET 41) (Figure 12) and 2 µL T4 DNA polymerase-treated
Ek/LICp62 insert. These were incubated at 22°C for 5 min then 1 µL 25 mM EDTA
was added to the mixture with stirring followed by incubation at 22°C for 5 min.
Annealing continued for 1 hr. We repeated the same process above separately with
the pET-32Xa/LIC insert of p62 using the same reaction conditions as described
above. The clones were digested by restriction enzymes and analyzed by agarose gel
electrophoresis to test the success of the LIC technique. A sample was sent for DNA
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sequencmg to verify cloning which was successful for both pET41Ek/LIC and
pET32Xa/LIC.

l::lpu11lf.l 1(2!l)
Xho 1(158)
1(158)
Eag 1(1661
Not 1(166)
Hind 111(1731
Sal 111791
Sac 1{190)
EcoR 1(192)
BamH,1{198)
EcoRV{206J

Ava

Nco 112111

BseR 1(2351
P'nAl(257)
Kpn 1(264)

Bgt ll{2e7)
Nsp V(294l

Sea 1�21)
Pwl(4w 11

...

Pst I 4721')
Bsa 1(4602)

SgrAl(See)

�"'\

�
�

Sph 1(1022)
V
EcoN 1(1082)

'1

i

�

C),
�

Ahd 14541)

pET-32 Xa/LIC
(5926bp)

lu 1(1M7)
Bdl(1M )

AlwN 1(4064)

BspLU11 l(:JMB)
Sap 1(3532)
Bst1107 l{l41Q)
Tlh111 1(33Q3)

Figure 11 Diagrammatic representation of the pET32Xa/LIC vector showing its
various restriction sites (LaVallie et al., 1993).
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2.4 Construction of double mutant by site-directed mutagenesis
The HAHi-containing plasmid was obtained from our laboratory freezer.
Mutagenesis was performed sequentially on the HAHl plasmid by Peter Sande and
Jubril Ayodele respectfully by mutating the cysteine at position 11 to alanine (Cl l A)
followed by cysteine 14 to alanine (Cl4A). The site-directed mutants of both HAHl
and the Wilson disease protein domain 4 (WLN4) were prepared starting with single
mutants HAHl(Cl l A) and WLN4(C15A) respectfully using the Stratagene kit.
Mismatched primers with the corresponding mutations were used with primer
extension by the proofreading polymerase Pful. Dpnl restriction enzyme digests were
used to remove the parental plasmid before transformation into Escherichia coli Nova
Blue

GigaSingles™

dideoxynucleotide

competent

sequencmg.

cells.
The

The

mutants

Stratagene

were

confirmed

Quick-Change

by

site-directed

mutagenesis kit was used to introduce the CllA and C14A mutation. The primers
were designed with the DNA Strider program. The sequence of the forward
mutagenic primers for pHAHl(Cl1A,C14A) were as follows 5' -G ACT GCC GGT
GGT GCC GCT GAA GCT GTA TCC CGG G -3' and the sequence of the reverse
mutagenic primer was 5'- CCC GGG ATA CAG CTT CAG CGG CAC CAC CGG
CAG TC -3'. Those for pTRX-WLN4(Cl5A,C18A) leading strand, 5'- G ACC GCT
GCA TCC GCT GTC CAT TCC ATT GAA GG C -3' and complementary strand, 5'
-GCC TTC AAT GGA ATG GAC AGC GGA TGC AGC GGT C -3'. The changed
amino acid codons are underlined. The reagents were mixed in a 1 mL
microcentrifuge tube following the protocol described in the Stratagene kit. The
solution was then overlaid with 30 µL of mineral oil and subjected to the PCR for
several cycles.
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2.4.1 Digestion of DNA by Dpnl enzyme
The non-mutated parental DNA was digested with Dpnl restriction enzyme
(10 U/µL). One µL (10 U/µL) of the restriction enzyme was added to the PCR
product. The reaction mixture was then centrifuged at 10,000 rpm for 1 mm m a
microcentrifuge. The mixture was then incubated at 37 °.C for 1 hr.
The plasmid containing the mutation construct was transformed into
NovaBlue GigaSingles E. coli cells according to the protocol: An aliquot of 200 µL
NovaBlue GigaSinglesTM competent cells (Novagen) was thawed on ice and mixed
gently to ensure that cells were evenly suspended and then added 1 µL (100 ng) of
DNA solution containing pHAHl(Cl1A,C14A) to the cells and stirred to mix. The
tubes were placed on ice for 5 min, heated for 30 sec in a 42°C water bath then placed
on ice for another 2 min before adding 250 µL of room temperature SOC media. The
cells were then incubated at 37 ° C while shaking at 250 rpm for 60 min prior to
plating.
The transformation product was plated on Luria Bertini broth (LB) agar plates
with 100 µg/mL Ampicillin and incubated at 37°C overnight. A few colonies obtained
from the transformation were inoculated into a 5 rnL starter culture of liquid LB for
plasmid recovery. The pure plasmid, pHAH(CllA,C14A) was recovered after
isolation and purification using Qiagen mini elute protocol.
Similarly, a site-directed mutagenesis was carried out on a single mutant of
the fourth domain of Wilson disease protein WLN4(C15A) to generate the pTRX
WLN4(C15A,C18A) a double mutant.
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2.5 Protein expression
The plasmid of p62 was transformed in E. coli cells Tuner(DE3) and the
product plated on LB culture containing 30 µg/mL kanamycin and incubated
overnight at 37 °C. An antibiotic, which is vector specific was used to make sure only
the resultant colonies are those of the desired protein. Several colonies observed on
the plates were inoculated and tested for protein expression. When the cells were
grown up to an OD of 0.6-1.0 an induction test was done with addition of 1 mM
IPTG for a period of 4 hr. The harvested bacterial cultures were centrifuged at
6000xg and the pellets were stored at -20°C. An aliquot withdrawn at each hr interval
were analyzed by SDS-PAGE.
After purifying the mutant gene of pTRX-WLN4(C15A,C18A), it was
transformed into Rosetta(DE3) cells using the following protocol described
previously above. A time-course induction in 1 mM IPTG (a synthetic mimic of the
natural inducer, 1,6- allolactose which binds to the lac repressor) was used to study
the protein expression on the 100 ml LB culture inoculated with mutated pTRX
WLN4(C15A,C18A) plasmid containing 100 µg/mL ampicillin. Aliquots of 500 µL
were withdrawn every 1 hr and centrifuged and stored at -20 °C until loaded onto a
15% SDS-PAGE gel in a Hoefer SE250 mini vertical gel electrophoresis unit. The
pellets were treated with 5 µL of loading buffer 2x and 20 µL of water then heated at
92 °C for 15 min before loading onto the gel which was then run for 1 hr at 98 mV
then stained with Coomassie blue stain for four hr and the gel was dried.
The pHAHl(CllA,C14A) plasmid was transformed into BL21 (DE3) cells
for protein expression using the protocol described above.
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2.5.1 Large scale protein expression
After the successful induction of pHAHl (Cl 1A,C14A) in a 100 mL aliquot of
BL21(DE3) cells, the cell culture was then over expressed in 10 L of LB. A fresh
colony of BL21(DE3) cells transformed with pHAHl(Cl lA,C14A) plasmid was
inoculated in 5 rnL LB media containing 100 µg/mL of ampicillin and grown in a
37 ° C incubator to an OD 600 of 0.6 and this was used as a starter culture to inoculate
10

L

of

LB.

This

pHAHl (Cl 1A,C14A)

batch

culture

of

BL21(DE3)

transformed

with

was grown aerobically in a New Brunswick Scientific

Microferm® fermentor to an OD600 of 0.6 before induction with 1 M IPTG to a final
concentration of 1 mM. After 4 hr the cells were harvested by centrifugation at 6,000
rpm for 15 min using an SLA 3,000 rotor. The pellets were then stored at -20° C prior
to protein extraction.
2.6 Protein purification
2.6.1 Freeze-thaw extraction
The freeze-thaw extraction buffer was 20 mM MES/N A, 1 mM EDTA, 10
mM dithiothreitol (DTT), pH 6. Protein extraction was performed by resuspending
the cell pellet in the freeze-thaw extraction buffer (24 mL of buffer per liter of
induction culture). The suspension was gently agitated in ice for 1 hr. The non
soluble portion was pelleted by centrifugation at 6000 g for 15 min. Both the
supernatant and the pellet were tested analytically by S D S-P AGE for the mutant
pHAHl (Cl 1A,C14A) protein . A positive result was finding the appropriate protein
in the supernatant sample, representing solubilized protein.
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CHAPTER III

RESULTS
3 .1 Cloning of p62 gene

The gene coding for p62 was amplified through 28 PCR cycles in a MiniCycle
using Deep Vent DNA polymerase (New England Biolabs). After running the agarose
gel electrophoresis with the PCR product it was found to be the appropriate size of
700 base pairs, (Figure 12).
1

2

3

1000 bp
p62
700 bp

500 bp

100 bp

Figure 12 1% agarose gel electrophoresis of p62 PCR product. Lane 1, is the 100bp
marker, Lanes 2 & 3 represent the p62 gene (~700 bp).

., .,
,.,,.,

The resultant PCR products were purified, double digested with restriction
endonucleases BarnHI and Ncol to get it out of the PCR fragment then cloned into
similarly digested pET24d E. coli expression vector. This ligation was digested with
BamHI and Ncol then analyzed by agarose gel electrophoresis and the right size of
p62 (700 bp) was visualized (Figure 14). The plasmid was then isolated for further
protein expression.
1

2

3

6 kb
5.0 kb
4 kb
3.0kb

4

5
pET24d
._ 5.1 kb

2.0 kb
1.5 kb
1 kb
._ p62700bp
0.5 kb

Figure 13 Ligation product of p62 into pET24d after restriction enzyme digestion
with BamHI and Ncol. Lane 1 represents 1 kb DNA ladder. Lanes 2-5 are
the ligation products (p62 size 700 hp).
The successful cloning in pET24d was verified by sequencing the gene (by
Retrogen) and also by restriction analysis of the recovered plasmid, both analyses
gave positive results. The cloned p62 gene was transformed into Rosetta cells and a
time-course induction test was performed. The induction did not work since no
expression of the protein was visualized.
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The difficulty of the above expression prompted another ligation method
using fusion techniques where we used Ligation Independent Cloning (LIC). First we
created two p62 constructs using the vectors pET41Ek/LIC and pET32Xa/LIC.
PCR products with the resultant complementary overhangs were created by
building 5' extensions into the primers. The PCR pro_duct was purified to remove
dNTPs (and template plasmid). After annealing of the LIC vector, it was transformed
into E. coli cells. Positive clones were transformed into Nova Blue GigaSingles E.
coli strains. Approximately 10 colonies appeared in the plates. Five colonies were
selected for screening by inoculation in 5 mL of LB containing 100 µg/mL
ampicillin. After reaching an OD of 0.6, the cell culture was centrifuged and the
pellet was recovered. The p62 plasmid DNA was then extracted using a Qiagen kit
before subjecting to restriction mapping.
The results of the Ligation Independent Cloning (LIC) where the cloned gene
was double-digested using restriction enzymes BamHI and Ncol showed that the
ligation was successful.
A band representing a fragment of the recombinant plasmid was observed on a
1% agarose electrophoresis gel (Figure 15 A & B). This confirmed that p62 was
successfully inserted into the vectors pET41Ek/LIC and pET32Xa/LIC respectively.
3.2 Induction of p62 in LB media
After the successful ligation using the LIC technique, the p62 gene was cloned
into Rosetta2(DE3) competent E. coli cells. An induction test using IPTG was carried
out with randomly selected colonies which were inoculated in LB media containing
30 µg/mL of kanamycin. The cultures were incubated at 37 °C with shaking.
Kanamycin was chosen as the appropriate antibiotic because the plasmid contained
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pET41 EK/UC

3 kb
2 kb
1.5 k

.

1 kb

B

1
6 kb
5 kb
4 kb
3 kb

2

3

4

p62 700 bp

5

pET32Xa/LIC

2 kb
1.5 kb
1 kb

0.5 kb

Figure 14 Confirmation of ligation both in:(A) pET41Ek/LIC and (B) pET32Xa/LIC
with a 1 % agarose gel electrophoresis showing the 700 base pair p62.
Lanes 2-5 show identical results.
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3.2

OD 600 (at time "zero")
X 15,uL
OD 600 (at time t)

genes for kanamycin resistance. We monitored the growth of the cells during
induction by measuring optical density at 600 nm (OD600 ). To induce the expression
of p62 gene we added 1 mM IPTG when the OD reached 0.6. IPTG is known to bind
and inactivate the lac operon repressor and therefore induces gene transcription by
RNA polymerase. Measuring of OD stopped after 4 hours. Samples withdrawn in
each time interval were centrifuged and analyzed by SDS-PAGE gel for the p62
induction. Loading on SDS-PAGE was normalized by the OD reading, equation
below.
The normalized loading on SDS-PAGE did not show the desired band with
time, thus, the expression was unsuccessful (Figure 16). This was evident from the
missing band 25 kDa on the gel above which corresponds with the size of p62.

k6'1
30.0
20.1
14.3
6.5
3.5

2

3

4

5

6

7

8

9
p62 in pET24d
24 kDa expected size

2.5

Figure 15 10 % SDS-PAGE electrophoresis results of p62 induction in E. coli. Lanes
2-9 represent the time-course induction while lane 1 represents the
Rainbow marker. There is no band corresponding to the induced protein as
expected with the horizontal arrow.
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3.3 Site-directed mutagenesis ofpHAHl(Cl 1A,Cl4A) and pTRX-WLN4
3.3.1 Protein expression ofpHAHl(CllA,Cl4A) in E .coli
Upon successful site-directed mutagenesis of the HAHl(CllA) single mutant
template to replace cysteine to alanine at position 14 recombinant plasmid
pHAH1(C11A,Cl 4A) was transformed into NovaBlue GigaSingles cells of E. coli.
The plasmid was isolated and purified. This plasmid was then transformed into
BL2 l(OE3) cells inoculated in LB and induced with IPTG for protein expression.
The expression of this protein was then analyzed by SOS-PAGE (Figure 1 7). A band
was visualized on SOS-PAGE gel to show that the four hour protein induction
worked.
M

45

0 hr

4

hr

kDa

30 kDa
20. 1 kDa

1 4.3 kDa
10

kDa

------ pH AH 1 (C11 A, C14A)
(-7.4 kDa)

Figure 16 10% SOS-PAGE electrophoresis of the small scale induction of the
pHAHl(Cl 1A,C14A) gene.Mis the marker.
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3.3.2 pHAHl(Cl l A,Cl4A) protein purification
Over expression on a large scale was conducted for pHAH1(C11A,C14A) in
BL2l(DE3 using a 10 liter LB culture for induction. This was performed using a New
Brunswick Microferm® Fermentor. Incubation conditions were set at 37 °C with 300
rpm, and l O psi of aeration. After 2 hr the cultures were induced with 1 mM IPTG
when the OD600 was 0.6. Bacterial pellets were treated to a freeze-thaw extraction to
selectively release soluble proteins.
M

0 hr

1 hr

2 hr

3 hr

pHAH1 (C11A,C14)

Figure 17 10% SDS-P AGE electrophoresis of the l O L 3 hr induction of the
pHAHl(Cl 1 A,Cl4A) showing the bands corresponding with the protein.
The first lane is the full range mo! wt. protein marker.
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pHAHl(CI IA,Cl4A)

Figure 18 10% SOS-PAGE electrophoresis showing the freeze-thaw results of
pHAHl(Cl 1A,C14A) protein purification. Lanes 2-4 are the supernatant
while lanes 5-7 pellet. Lane 1 represents the standard marker (Rainbow).

1

2

3

4

X

HAH1 (C11A,C14A)

Figure 19 10% SDS-PAGE electrophoresis showing the purified
pHAHl(Cl1A,Cl4A) lanes 2-4. Lane 1 represents the standard marker
(Rainbow).The higher molecular bands (X) are due to oxidation induced
dimerization.
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Expression

and

purification

of

the

mutated

metallochaperone,

pHAHl(Cl 1A,Cl 4A) proved to be successful. As predicted, during large scale
protein expression, the protein was expressed only after induction (Figure 17). The
amount of protein

increased with time. Using the freeze-thaw method,

pHAHl(Cl 1A,C14A) was extracted from BL21(DE3)-E. coli expression cells along
with a large amount of unwanted E. coli protein.
After freeze-thaw extraction, both the supernatant and pellet were analyzed by
SDS-P AGE electrophoresis. The pHAHl(Cl 1A,Cl 4A) protein appeared to be
soluble because the band was seen in the supernatant (Figure 18). The freeze-thaw
extract of the protein pHAHl(Cl 1A,C14A) was further purified with DE AE anion
exchange column to isolate it from other contaminating proteins. The protein elution
was monitored by the UV absorption profile at 254 nm.
3.4 Protein expression of pTRX-WLN4(C15A,C18A)
Site-directed mutagenesis was done to create a double mutant using the single
mutant of Wilson Disease protein fourth domain, WLN4(Cl 5A). The resultant
plasmid, pTRX-WLN4(C15A,C18A) with two cysteine residues changed to alanine
at positions 15 and 18 was transformed into XL-II Gold cells of E. coli. The plasmid
was then isolated and purified (Figure 21).
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1
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3

10 kb
5.0 kb
3.0kb
2.0 kb
1 kb

0.5 kb

Figure 20 1% agarose gel electrophoresis of the site-mutagenesis results of pTRX
WLN4(Cl 5A,Cl 8A). Lanes 2 represent the band corresponding to the 7
kb size of WLN4. Lane 3 represents the WLN4(C15A) plasmid template.

1
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3

4

5

6

45 K
30 K
20.1 K

pTRX-WLN4(C15A,C1 SA)

14.3 K
6.5 K

Figure 21 10% SDS-P AGE electrophoresis showing the initial time-course induction
results of the double mutant of the pTRX-WLN4(C15A,C18A). Lane 1
represents the protein marker and Lanes 2-6 represent 4 hr induction.
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Agarose gel electrophoresis was used to analyze the site-directed mutagenesis
results and a band appeared corresponding to the size of the linearized full-length
plasmid of 7 kb. The DNA sequence was confirmed by Retrogen (San Diego, CA).
The pTRX-WLN4(Cl5A,C18A) plasmid was transformed into Rosetta(DE3)

E. coli cells and induced for protein expression in LB media containing 100 µg/L
ampicillin with 1 mM IPTG and the results analyzed by SDS-PAGE gel (Figure 21).
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CHAPTER IV

DISCUSSION
To investigate the potential copper-dependent interaction of p62 subunit of the
dynactin complex with the Wilson disease protein, attempts were made to clone and
express the p62 protein. The first step was to obtain the p62 gene and amplify it with
the polymerase chain reaction (PCR). Cloning results were verified by DNA
sequencing carried out by Retrogen. A double digestion of the plasmid by restriction
enzymes BamHI and Ncol proved that the ligation worked since the mass
corresponding to both the p62 DNA (700 bp) and pET 24d vector (5.1 kb) were
visible on the agarose gel electrophoresis (Figure 13). The next step was to express
the cloned plasmid into E. coli cells, Rosetta2 cells. After several expression attempts
of the cloned gene the protein seemed not to express upon induction as seen in the
SDS-PAGE gel (Figure 15). This could be due to protein aggregation or, during the
induction, toxic metabolites of p62 protein are formed which hinder the expression.
Another cloning strategy whereby we used a fusion protein to try and enhance the
expression of this protein was developed. Ligation independent cloning technique
(LIC) is a directional cloning technique that does not utilize use of restriction enzyme
digestion. First, the p62 gene was cloned into pET42Ek/LIC which has a fusion
glutathione s-transferase (GST-tag) and secondly in pET32Xa/LIC which has a
thioredoxin fusion tag. The importance of expressing a protein using a fusion protein
is to make it more soluble (LaVallie et al., 1993). After obtaining the plasmid (Figure
14), the cloning was verified by the same methods mentioned above, DNA
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sequencing and restriction endonuclease digestion. We then expressed the resultant
p62 plasmid in E. coli Rosetta cells. A time-course induction was carried out and the
protein induced with IPTG for protein expression which again was not successful.
Another alternative strategy to express the p62 gene was developed. Yeast
expression systems are known to enhance some prote_in expression which may not
express well in E. coli. Pichia pastoris is a methylotrophic yeast which has been
developed into a heterologous protein expression system. Pichia pastoris combines
many of the benefits of E. coli expression with the advantages of expression in a
eukaryotic

system

(e.g.

protein processing,

folding,

and

posttranslational

modifications). The Pichia Expression System (Invitrogen) has several advantages
over other eukaryotic or prokaryotic systems which may include strong constitutive
and inducible promoter, high levels of expression and eukaryotic posttranslational
modifications (Invitrogen).
Pichia pastoris is a strain of yeast capable of metabolizing methanol as the
sole carbon source. The first step in the metabolism of methanol is the oxidation of
methanol to formaldehyde by the enzyme, alcohol oxidase. Expression of this
enzyme, coded for by the AOXl gene, is tightly regulated and induced by methanol
to very high levels-typically >30% of the total soluble protein in the cells. The
Pichia Expression System utilizes the AOXl promoter for inducible expression or the
GAP promoter for constitutive expression of the gene of interest (Hohenblum et al.,
2004).
We have proposed other alternative cloning strategies to enhance the
expression of p62 subunit of the dynactin complex apart from the yeast strategy
described above. The first technique we suggest uses a Maltose binding protein fusion
technique. Maltose Binding Protein (MBP) forms part of the maltose/maltodextrin
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system of E. coli bacteria, which is responsible for the uptake and efficient catabolism
of maltodextrins (Boos & Shuman, 1998). E. coli maltose binding protein (MBP) is
used as a fusion partner for recombinant protein expression. Because of its affinity for
maltodextrins it allows for facile purification of fusion proteins by amylase affinity
chromatography which uses a chemically cross-linked starch (Riggs, 2000).
Since p62 protein has been difficult to express on its own may this technique
may be used to improve its solubility once it is fused and expressed with MBP
(Kapust & Waugh, 1999; Pryor & Leiting, 1997). Previous work done by Kapust and
Waugh indicate that MBP is a much better solubilizing agent than either glutathione
S-transferase (GST) or thioredoxin (TRX) fusion proteins (Kapust & Waugh, 1999).
It has been suggested previously that MBP enhances the solubility of aggregation
prone proteins because it possesses chaperone-like qualities which allow it to bind
reversibly to folding intermediates of its fusion partners, termed passenger proteins
(Fox et al., 2001). This binding temporarily sequesters them in a conformation that
prevents their self-association and aggregation (Kapust & Waugh, 1999).
The purified recombinant p62 protein expressed with the MBP will be
analyzed by an SDS-PAGE gel then eluted from the amylose column. The protein is
then cleaved after elution by treatment with the protease called Factor Xa. Finally the
pure protein is removed by passing the mixture over another amylose column where
the recombinant protein simply passes through the column without binding.
4.1 Gateway cloning technology is another alternative cloning technique
Gateway cloning technology (lnvitrogen) is a recent methodology that may
represent another cloning strategy to enhance the expression of the p62 protein. It
works by facilitating protein expression, cloning of PCR products, and analysis of
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gene function by replacing restriction endonucleases and ligase with site specific
recombination. The Gateway technology is rapid and utilizes a wide range of cloning
vectors besides maintaining the orientation and reading frame of the transferred DNA.
The first step involves inserting your gene of interest into the Gateway system by way
of an entry clone. Once the entry clone has been formed it is available to express your
gene in a variety of other vectors as illustrated in the diagram below (Figure 23).

(

(

mal E

Target Gen•

!Mesi
a
rJ Cloning

4J.,

lJ

&
E xpressl on

Target
Protein
n

Load & VVash
Target
Protein

R

EI ute VVit h Mal tose
Target
Protein

MBP
n

i

Cleave VVlt h
Specific Pr otease

�-....�
�

�

Figure 22 The illustration shows how the MBP purification works (BioLabs Inc).
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Figure 23 An illustration of Gateway cloning technique. DNA segment (gene) is
transferred from an entry clone into any number of recipient vectors
(destination vectors) to generate expression clones.
The sources of your gene could be from a restriction endonuclease digestion
and ligation, from a polymerase chain reaction or from a cDNA library. The
generated expression clones generated are then transformed into E. coli cells for the
p62 protein expression.
The second phase of this project involved the study of how the Atxl human
homolog (HAHl) interacts with the fourth N-terminal domain of the Wilson disease
protein. A single mutant of HAH1 (C 11A) was obtained from our laboratory. Site
directed mutagenesis was carried out to generate the HAHl double mutant in which
two cysteine residues were mutated to alanine at positions 11 and 14. When
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holoCu(I)HAH 1 is titrated with apo WLN4, chemical shift changes occur in a number
of residues (Figure 24) with the shift changes increasing upon addition of apo WLN4.
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Figure 24 Complex formation between Cu(I)HAH 1 and WLN4 with the weighted
average chemical shift differences. The secondary structure elements of
Cu(I)HAH 1 are reported at the top of the graph. The threshold is indicated
with a horizontal red line. (Achila et al., 2006).
During the copper transfer between HAHl and WLN4 a complex is formed
between the two as shown in the illustration below (Achila et al., 2006). The
CxxC-AxxA mutant of each protein should not form this complex, since a thiol is
required for complex formation (Banci et al., 2006).
Cu(l)HAH I + WLN4

HAH I/Cu(l)/WLN4
adduct

HAHi+
Cu(I)WLN4

Figure 25 Complex formation between Cu(I)HAH 1 and WLN4.
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In native forms HAHl forms a complex with WLN4 that allows the transfer
of copper between these partners. This is due to the C xxC motif of the cysteine
residues present in both. By mutating the two cysteines into alanine copper exchange
is not possible between the two.
This double mutant was used to serve as a negative control of the copper
transfer studies between the two proteins HAHl and WLN4. The double mutant
plasmid was confirmed by DNA sequencing. The plasmid was then expressed in
BL21(DE3)

E.

coli

cells (N ovagen)

with

a

time-course

induction

of

pHAHl(Cl1A,C14A) in 1 mM IPTG .. The expression was successfu l. During the
induction with IPTG, T7 polymerase then translates the mutated gene. BL21(DE3)
cells were used because they contain chromosomal copy of the T7 RNA polymerase.
SDS-PAGE gel, results show the induction was successful. A band is seen to
intensify with time of induction up to 4 hrs (Figures 16-1 7).
•.
To purify the pHAHl(Cl1A,C14A) a freezing and thawing cycle was carried

out and after analysis using SDS-PAGE. The protein was soluble and easily extracted
as it appeared to be in the supernatant (Figure 18 ). Mutating two cysteine residues of
WLN4 at positions 15 and 18 was made possible by site-directed mutagenesis of the
single mutant WLN4(C15A). The double mutant gene pTRX-WLN4(Cl5A,C18A)
was verified by DNA sequencing and the alignment confirmed by the DNA Strider
program in our laboratory. We then expressed the plasmid in Rosetta2(DE3) E. coli
cells (Figure 21 ).
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CHAPTERV

CONCLUSION
The Wilson disease protein interacts with other proteins, p62 subunit of the
dynactin complex and HAHi in a copper-dependent manner that requires cysteine
residues of CxxC motif (Larin et al., 1999; Lim et al., 2006). The aim of this study
was to clone purify and characterize p62 subunit of the dynactin complex and study
its copper interaction with the N-terminal domains of the Wilson disease protein. We
also aimed at generating double mutants of both HAHi human ATXl homolog and
the fourth domain of Wilson disease protein (WLN4) by mutating two cysteine
residues into alanine
We have cloned p62 into pET24d, pET41Ek/LIC and pET32Xa/LIC. We have
successfully cloned, over expressed and purified pHAHl(CllA,C14A) and pTRX
WLN4(C15A,Cl8A). The copper interactions studies will help enhance the
understanding of the best-known disorders of copper homeostasis, Wilson's disease
and Menkes disease, and avail more information on the molecular mechanisms that
control the distribution of copper in living cells.
We propose alternative cloning strategies for the p62 protein, such as the yeast
two-hybrid expression using Pichia pastoris. Another proposed alternative expression
technique for the p62 subunit of the dynactin complex includes the use of the Maltose
binding protein fusion and also the Gateway cloning technology to enhance
expression of p62 in E. coli.

..

Once the p62 protein has been expressed and purified we, intend to determine
which amino acid residues are responsible for this copper-dependent interaction. We
have proposed various analytical techniques including that will help achieve this goal.
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These will include NMR titrations; the copper environment of p62 will be explored
by metal-binding studies, XANES, and EXAFS experiments.
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